je.st
news
Medivir announces that Janssen has started a phase I study to...
2015-08-03 17:02:50| Appliances - Topix.net
Medivir AB today announces that Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies has started a phase I clinical trial to evaluate the potential effect of simeprevir and odalasvir , on the pharmacokinetics of AL-335 in healthy volunteers. This phase I study is an open-label, two-group study of simeprevir, odalasvir, a hepatitis C virus NS5A inhibitor, and of AL-335, a nucleotide-based HCV polymerase inhibitor.
Tags: to
study
started
phase
Category:Consumer Goods and Services
Latest from this category |
All news |
||||||||||||||||||
|